AI-generated summary
This retrospective study of eleven patients with refractory oral chronic graft-versus-host disease reports that photobiomodulation therapy was associated with lower self-reported pain immediately after treatment in most sessions. The authors describe the relief as rapid and lasting a mean of about six days, with no adverse effects reported, but the design is retrospective and the sample is small.
- Participants
- 11
- Who or what was studied
- Eleven patients with oral ulcers from chronic graft-versus-host disease refractory to topical corticosteroids
- Wavelengths
- 940 nm
- Limits stated in the abstract
- Retrospective design with a small sample of eleven patients and no control group, and the abstract does not describe a comparator.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 940 nm
- Power density (irradiance)
- 98.6 mW/cm2
- Power
- 0.7 W
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Laser, Duty cycle, Irradiance. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.